Brief: Tango Therapeutics Q1 Basic EPS USD -0.35
08/05/2024 12:00
May 08 (Reuters) - Tango Therapeutics Q1 operating income USD -42.255 million vs. IBES estimate USD -33.3 million. * Q1 net income USD -37.914 million vs. IBES estimate USD -31.5 million * Q1 operating expenses USD 48.726 million
Recent news on Tango Therapeutics
See all newsBrief: Tango Therapeutics, Inc. Approved A Strategic Reprioritization Of The Company’S Research And Development Activities
Brief: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Tango Therapeutics - Files Prospectus To Sell Up To $400 Million In Common Stock
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,